Fever News and Research

RSS

KU Leuven scientists develop new vaccine against Zika virus

Scientists at the KU Leuven Rega Institute in Belgium have developed a new vaccine against the Zika virus. This vaccine should prevent the virus from causing microcephaly and other serious conditions in unborn babies.

19 Dec 2018

Pregnant women and extremely obese people at high risk of flu complications

Pregnant women and the extremely obese are among those at high risk for complications from the flu - including death - and should be tested and begin antiviral treatment promptly if they are sick enough to be hospitalized with flu symptoms, according to updated guidelines released by the Infectious Diseases Society of America.

19 Dec 2018

Hepatitis C drug can eliminate chikungunya, yellow fever virus

A study performed at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil shows that sofosbuvir, a drug used to treat chronic hepatitis C, is capable of eliminating chikungunya virus and yellow fever virus.

19 Dec 2018

Study finds high prevalence of TB infection among Tibetan refugee schoolchildren

In a tuberculosis screening and treatment initiative covering the entire population of Tibetan refugee schoolchildren in northern India, a team directed by researchers at Johns Hopkins Medicine and the University of Wisconsin says it has found not only a startlingly high prevalence of TB disease and infection, but also a potentially workable strategy to eliminate the disease in a large, high-risk group.

19 Dec 2018

Immune cells explode themselves to inform about the danger of invading bacteria

Our immune systems are working overtime this time of year. Knowing that a bunch of dedicated immune cells are willing to explode themselves to inform other cells about the danger may offer a bit of consolation.

17 Dec 2018

"Miracle" baby survives Ebola in Congo and rapid a new Ebola detection device

A female baby was diagnosed with the deadly Ebola when she was only six days old. According to the health officials in the Democratic Republic of the Congo (DRC), she seemed to have miraculously recovered from the viral infection.

17 Dec 2018

Genetically modified pigs could limit replication of classical swine fever virus, study shows

Researchers have developed genetically modified pigs that are protected from classical swine fever virus, according to a study published December 13 in the open-access journal PLOS Pathogens by Hongsheng Ouyang of Jilin University, and colleagues.

14 Dec 2018

Genetic study reveals new insights into underlying causes of moderate-to-severe asthma

The largest-ever genetic study of people with moderate-to-severe asthma has revealed new insights into the underlying causes of the disease which could help improve its diagnosis and treatment.

13 Dec 2018

Salk professor receives $1.8 million from NOMIS Foundation for research on mechanisms to promote health

Associate Professor Janelle Ayres has been awarded $1.8 million over two years by the NOMIS Foundation to study health as an active process in which microbes--including the trillions of microorganisms that call the human body home--initiate interactions that promote the health of the host.

13 Dec 2018

Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain

Researchers from the Virginia Tech School of Neuroscience are teaming with the University of California San Diego and the U.S. National Institutes of Health to develop a drug -- now in its earliest stages -- that can treat certain types of chronic pain without the addictive consequences of opioids.

12 Dec 2018

Early gut bacterial colonization may reduce risk of developing eczema

Strains of a bacterium commonly found in skin infections may help to protect against eczema, according to new research in the British Journal of Dermatology.

4 Dec 2018

Clearer diagnosis of polio-like illness in young children

Johns Hopkins researchers have analyzed patient data from 45 cases of what they thought was acute flaccid myelitis, the polio-like outbreak occurring in U.S. children, and realized that only 75 percent of diagnosed cases were AFM.

4 Dec 2018

New study launched in Burkina Faso to test typhoid conjugate vaccine

A new study has been launched in Burkina Faso for Bharat Biotech's typhoid conjugate vaccine. It is the second clinical study underway in Africa for the vaccine and the first in West Africa.

4 Dec 2018

New strategies may improve performance of CAR-T cell therapy in treating cancer

Mayo Clinic researchers have developed two new strategies that may improve the performance of chimeric antigen receptor therapy in treating cancer. They are presenting results of their preclinical research at the 2018 annual meeting of the American Society of Hematology in San Diego.

3 Dec 2018

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).

3 Dec 2018

New report reveals effects of climate change, air pollution on human health

IIASA researchers have contributed to a major new report in The Lancet medical journal looking at the effects of climate change on human health, and the implications for society.

29 Nov 2018

Researchers generate six antibodies to diagnose and treat Zika virus

Researchers have generated six Zika virus antibodies that could be used to test for and possibly treat a mosquito-borne disease that has infected more than 1.5 million people worldwide.

29 Nov 2018

The Native Antigen Company launches ground-breaking Zika virus immunoassays

The Native Antigen Company has launched a series of ground-breaking immunoassays for Zika virus, offering researchers in academia, public health and drug discovery the capability to work with unprecedented levels of specificity and sensitivity.

29 Nov 2018

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

29 Nov 2018

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

The U.S. Food and Drug Administration today approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin's lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.

29 Nov 2018

Fever News and Research

KU Leuven scientists develop new vaccine against Zika virus

Pregnant women and extremely obese people at high risk of flu complications

Hepatitis C drug can eliminate chikungunya, yellow fever virus

Study finds high prevalence of TB infection among Tibetan refugee schoolchildren

Immune cells explode themselves to inform about the danger of invading bacteria

"Miracle" baby survives Ebola in Congo and rapid a new Ebola detection device

Genetically modified pigs could limit replication of classical swine fever virus, study shows

Genetic study reveals new insights into underlying causes of moderate-to-severe asthma

Salk professor receives $1.8 million from NOMIS Foundation for research on mechanisms to promote health

Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain

Early gut bacterial colonization may reduce risk of developing eczema

Clearer diagnosis of polio-like illness in young children

New study launched in Burkina Faso to test typhoid conjugate vaccine

New strategies may improve performance of CAR-T cell therapy in treating cancer

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

New report reveals effects of climate change, air pollution on human health

Researchers generate six antibodies to diagnose and treat Zika virus

The Native Antigen Company launches ground-breaking Zika virus immunoassays

FDA approves new drug for treatment of rare autoimmune disorder

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News